SCHEMBL4064009

SCHEMBL4064009

Cn1c(-c2ccncc2)c(C(=O)O)c2cccnc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 1/20 0.46
SRC P12931 1/20 0.46
FEN1 P39748 1/20 0.43
KDM4C Q9H3R0 3/20 0.42
KDM4E B2RXH2 3/20 0.42
KDM5A P29375 2/20 0.42
KDM6B O15054 2/20 0.42
KDM5B Q9UGL1 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.40
ALDH1A1 P00352 3/20 0.39
POLB P06746 1/20 0.39
HPGD P15428 1/20 0.39
DHODH Q02127 4/20 0.39
NSD3 Q9BZ95 1/20 0.38
AGTR1 P30556 2/20 0.38
MAPK14 Q16539 1/20 0.38
NAMPT P43490 1/20 0.38
HTT P42858 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.37
NPC1 O15118 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6477966 0.92 EGFR (0.51) EGFRSRCFEN1KDM4EALDH1A1
SCHEMBL7489307 0.80 ALDH1A1 (0.58) EGFRKDM4EALDH1A1POLBHPGD
SCHEMBL6487256 0.78 ABCB1 (0.43) EGFRSRCFEN1KDM4CKDM4E
SCHEMBL6487252 0.78 ABCB1 (0.43) EGFRSRCFEN1KDM4CKDM4E
SCHEMBL15074638 0.77 NSD3 (0.49) KDM4EALDH1A1POLBHPGDDHODH
SCHEMBL21979475 0.77 EGFR (0.50) EGFRSRCFEN1KDM4CKDM4E
SCHEMBL6485737 0.72 CYP1A2 (0.42) KDM4EALDH1A1POLBHPGDDHODH
SCHEMBL29912955 0.72 CYP1A2 (0.42) KDM4EALDH1A1POLBHPGDDHODH
SCHEMBL4064012 0.72 USP14 (0.47) FEN1KDM4CKDM4EKDM5AKDM6B
SCHEMBL11078500 0.71 FEN1 (0.52) EGFRSRCFEN1KDM4CKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1641791-B1 3-(GUANIDINOCARBONYL)HETEROCYCLE DERIVATIVES, PREPARATION PROCESS AND INTERMEDIATES OF THIS PROCESS, THEIR USE AS MEDICAMENTS, AND PHARMACEUTICAL COMPOSITIONS INCLUDING THEM SANOFI AVENTIS DEUTSCHLAND (DE) 2009-07-29 EP disclosed